ARTICLE | Company News
Coley, Aventis in asthma deal
August 6, 2001 7:00 AM UTC
Coley (Wellesley, Mass.) granted AVE exclusive worldwide rights to its CpG 9328 immune modulator and up to three additional oligonucleotides identified by Coley's Human Cell Screening technology for a...